The  	The  	 DT	O
effect  	effect  	 NN	O
of  	of  	 IN	O
streptozotocin  	streptozotocin  	 NN	B-NP
and  	and  	 CC	O
alloxan  	alloxan  	 NN	B-NP
on  	on  	 IN	O
the  	the  	 DT	O
mRNA  	mRNA  	 JJ	B-NP
expression  	expression  	 NN	I-NP
of  	of  	 IN	O
rat  	rat  	 JJ	O
hepatic  	hepatic  	 JJ	B-NP
transporters  	transporters  	 NN	I-NP
in  	in  	 IN	O
vivo  	vivo  	 VBG	B-NP
The  	The  	 DT	O
effect  	effect  	 NN	O
of  	of  	 IN	O
streptozotocin  	streptozotocin  	 NNS	B-NP
( 	( 	 -LRB-	O
STZ 	STZ 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
alloxan  	alloxan  	 NNS	B-NP
( 	( 	 -LRB-	O
ALX 	ALX 	 NNP	B-NP
)  	)  	 -RRB-	O
on  	on  	 IN	O
the  	the  	 DT	O
hepatic  	hepatic  	 JJ	B-NP
messenger  	messenger  	 NN	I-NP
RNA  	RNA  	 NNP	I-NP
( 	( 	 -LRB-	O
mRNA 	mRNA 	 NNP	B-NP
)  	)  	 -RRB-	O
expression  	expression  	 NN	O
of  	of  	 IN	O
four  	four  	 CD	O
transporters  	transporters  	 NNS	B-NP
( 	( 	 -LRB-	O
Mrp2 	Mrp2 	 NNP	B-NP
,  	,  	 ,	O
Mdr1 	Mdr1 	 NNP	B-NP
,  	,  	 ,	O
Oct1 	Oct1 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
Oatp1 	Oatp1 	 CD	B-NP
)  	)  	 -RRB-	O
was  	was  	 VBD	O
studied  	studied  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
present  	present  	 JJ	O
work 	work 	 NN	O
.  	.  	 .	O
After  	After  	 IN	O
the  	the  	 DT	O
healthy  	healthy  	 JJ	O
male  	male  	 JJ	O
Wistar  	Wistar  	 JJ	B-NP
rats  	rats  	 NNS	I-NP
were  	were  	 VBD	O
individually  	individually  	 RB	O
treated  	treated  	 VBN	O
by  	by  	 IN	O
a  	a  	 DT	O
single  	single  	 JJ	O
intraperitoneal  	intraperitoneal  	 JJ	B-NP
injection  	injection  	 NN	I-NP
of  	of  	 IN	I-NP
ALX  	ALX  	 NNP	I-NP
monohydrate  	monohydrate  	 NNS	I-NP
( 	( 	 -LRB-	O
150 mg 	150 mg 	 FW	O
/ 	/ 	 FW	O
kg 	kg 	 FW	O
)  	)  	 -RRB-	O
or  	or  	 CC	O
STZ  	STZ  	 NNP	B-NP
( 	( 	 -LRB-	O
50 mg 	50 mg 	 FW	O
/ 	/ 	 FW	O
kg 	kg 	 FW	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
the  	the  	 DT	O
hepatic  	hepatic  	 JJ	B-NP
mRNA  	mRNA  	 JJ	I-NP
expression  	expression  	 NN	I-NP
levels  	levels  	 NNS	I-NP
of  	of  	 IN	I-NP
Mrp2 	Mrp2 	 NNP	I-NP
,  	,  	 ,	O
Mdr1 	Mdr1 	 NNP	B-NP
,  	,  	 ,	O
Oct1 	Oct1 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
Oatp1  	Oatp1  	 NNP	B-NP
were  	were  	 VBD	O
detected  	detected  	 VBN	O
by  	by  	 IN	O
real-time  	real-time  	 JJ	B-NP
quantitative  	quantitative  	 JJ	I-NP
PCR 	PCR 	 NNP	I-NP
.  	.  	 .	O
The  	The  	 DT	O
results  	results  	 NNS	O
indicated  	indicated  	 VBD	O
that  	that  	 IN	O
the  	the  	 DT	O
mRNA  	mRNA  	 JJ	B-NP
expression  	expression  	 NN	I-NP
levels  	levels  	 NNS	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
Mrp2 	Mrp2 	 NNP	I-NP
,  	,  	 ,	O
Mdr1 	Mdr1 	 NNP	B-NP
,  	,  	 ,	O
Oct1 	Oct1 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
Oatp1  	Oatp1  	 CD	B-NP
in  	in  	 IN	O
ALX-induced  	ALX-induced  	 JJ	B-NP
diabetic  	diabetic  	 JJ	I-NP
rats 	rats 	 NNS	I-NP
,  	,  	 ,	O
as  	as  	 RB	O
well  	well  	 RB	O
as  	as  	 IN	O
the  	the  	 DT	O
hepatic  	hepatic  	 JJ	B-NP
mRNA  	mRNA  	 JJ	I-NP
expression  	expression  	 NN	I-NP
of  	of  	 IN	I-NP
Mdr1  	Mdr1  	 NNP	I-NP
and  	and  	 CC	O
Oatp1  	Oatp1  	 CD	B-NP
in  	in  	 IN	O
STZ-induced  	STZ-induced  	 JJ	B-NP
diabetic  	diabetic  	 JJ	I-NP
rats 	rats 	 NNS	I-NP
,  	,  	 ,	O
were  	were  	 VBD	O
significantly  	significantly  	 RB	O
decreased  	decreased  	 VBD	O
as  	as  	 RB	O
compared  	compared  	 VBN	O
with  	with  	 IN	O
the  	the  	 DT	O
control 	control 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
inhibition  	inhibition  	 NN	O
of  	of  	 IN	O
ALX  	ALX  	 NNP	B-NP
and  	and  	 CC	O
STZ  	STZ  	 NNP	B-NP
on  	on  	 IN	O
hepatic  	hepatic  	 JJ	B-NP
transporter  	transporter  	 NN	I-NP
expression  	expression  	 NN	I-NP
suggested  	suggested  	 VBD	O
that  	that  	 DT	O
alterations  	alterations  	 NN	O
of  	of  	 IN	O
drug  	drug  	 NN	B-NP
transporters  	transporters  	 NN	I-NP
under  	under  	 IN	O
diabetic  	diabetic  	 JJ	B-NP
condition  	condition  	 NN	I-NP
can  	can  	 MD	O
be  	be  	 VB	O
responsible  	responsible  	 JJ	O
for  	for  	 IN	O
reduced  	reduced  	 JJ	O
drug  	drug  	 NN	B-NP
clearance 	clearance 	 NN	I-NP
.  	.  	 .	O
